Short answer
NEOGENOMICS INC (NEO) filed an 8-K current report with the SEC on June 22, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events). Notes sold privately under Section 4(a)(2) and Rule 144A, limiting immediate liquidity and resale to qualified institutional buyers.
NEOGENOMICS INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.01 · Entry into a Material Definitive Agreement
- Notes sold privately under Section 4(a)(2) and Rule 144A, limiting immediate liquidity and resale to qualified institutional buyers
- Conversion initially capped at 30,147,733 common shares, creating potential substantial dilution
- Initial conversion rate: 95.3288 shares per $1,000 principal amount
- Conversion shares generally unregistered, with issuance relying on Section 3(a)(9) exemption
Item 8.01 · Other Events
- $276.0M principal of 0.25% 2028 convertible notes repurchased for $263.19M cash, reducing future dilution and debt
- Partial termination of capped calls with BofA, Morgan Stanley and Goldman Sachs, matching repurchased note amounts
- Up to $25.0M of common shares repurchased from note purchasers at $10.49 per share
- Transactions indicate capital structure optimization alongside the new Notes offering, with cash deployed for debt and equity reduction
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other NEOGENOMICS INC 8-K filings
Get the next NEO 8-K as it lands
Follow NEO for push alerts, or ask the research agent what this filing means.